People · Operator
Named in public records as an officer, director or promoter · active 2010–2022 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sorbent Therapeutics Inc | — | Pharmaceuticals | Series B | $58.6M | $221.0M | 2010 |
| Achieve Life Sciences, Inc. | — | Biotechnology | Series B | $28.9M | $270.0M | 2022 |
Donald Joseph at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Donald Joseph on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Healy | 1 | 8 |
| David Collier | 1 | 8 |
| Scott Minick | 1 | 7 |
| James I. Healy | 1 | 7 |
| Markus Goebel | 1 | 4 |
| Linda Ara | 1 | 3 |
| John Bencich | 1 | 3 |
| Cindy Jacobs | 1 | 2 |
| Jay Moyes | 1 | 2 |
| Randall Woods | 1 | 2 |
| Michael A. Martino | 1 | 2 |
| Howard C. Dittrich | 1 | 2 |
| Anthony Clarke | 1 | 2 |
| David I. Collier | 1 | 1 |
| William I. Rajski | 1 | 1 |
| Bridget Martell | 1 | 1 |
| Martin Mattingly | 1 | 1 |
| Jaime Xinos | 1 | 1 |
| Vaughn Himes | 1 | 1 |
| Richard Stewart | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.